美国

TEVA PHARMACEUTICALS USA

会员限时活动

1580 元/年

交易概况

总交易额

2,419,939.72

交易次数

49

平均单价

49,386.52

最近交易

2025/05/17

TEVA PHARMACEUTICALS USA 贸易洞察 (供应商)

过去5年，TEVA PHARMACEUTICALS USA在美国市场展现出 交易非常活跃，今年已有多笔成交。 总交易额达 2,419,939.72 ，累计 49 笔交易。 平均单价 49,386.52 ，最近一次交易于 2025/05/17。

贸易记录

日期 交易公司 交易描述 数量 金额
2023-10-11 WATSON PHARMA PRIVATE LIMITED Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. containing antibiotics, hormones or stero... 3.00NOS 15275.52USD
2024-02-15 WATSON PHARMA PRIVATE LIMITED (FOC) Tolvaptan Tablets 30mg/15mg 00480-3311-66 (Stability samples) 2780.00NOS 36254.68USD
2023-04-24 WATSON PHARMA PRIVATE LIMITED Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. containing antibiotics, hormones or stero... 448.00TBS 175708.03USD
2025-05-17 ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED (100% EOU) (FOC)TEVA-CEPHALEXIN TABLETS,500MG ITEM.00093-8007-05 LOT.100070321 (FOR RESEARCH&TESTING PURPOSES ) (18BTL)(100% EOU) (FOC) TEVA-CEPHALEXIN TABLETS,500MG ITEM.00093-80 18.00NOS 816.12USD
2023-09-25 CIPLA LIMITED Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. containing antibiotics, hormones or stero... 5.00NOS 1410.05USD
2025-05-15 WATSON PHARMA PRIVATE LIMITED (FOC) Filspari (Sparsentan) 400mg Tablets 30 ct (For R&D useonly)(FOC) Filspari (Sparsentan) 400mg Tablets 30 ct (For R&D use 240.00TBS 99458.16USD

贸易国家分析

HS编码情报

HS编码 产品描述 频次
854140 光电二极管、晶体管、类似半导体器件 42
847130 便携式数字处理设备 35
851762 无线网络接入设备 28
847330 电子计算机零件 22
852910 天线和天线反射器 18
853400 印刷电路板 15